"Since late 2004, OneWorld Health, UC Berkeley and Amyris have been working together as the Artemisinin Project to develop a new, low-cost technology platform to provide non-seasonal, high-quality and affordable artemisinin - semisynthetic artemisinin - a key ingredient in first-line treatments for malaria."